CIP2A is a target of bortezomib in human triple negative breast cancer cells

Tseng, Ling-Ming, Liu, Chun-Yu, Chang, Kung-Chi, Chu, Pei-Yi, Shiau, Chung-Wai, Chen, Kuen-Feng·2012·Breast Cancer Research
DOI 10.1186/bcr3175

Cited by (122)

Items 101–122 of 122

  1. CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells
    Xudong Chen, Shi-Xiong Tang, Jian-Hua Zhang, Litao Zhang, Yao-wen Wang · 2017 · Oncology Reports · Retracted
  2. Expression of cancerous inhibitor of protein phosphatase 2A in human triple negative breast cancer correlates with tumor survival, invasion and autophagy
    Shan Li, Tingting Feng, Yang Guo, Xianjun Yu, Qiuyue Huang, Liang N. Zhang, Wei Tang, Ying Liu · 2016 · Oncology Letters
  3. BDP1 Alterations Correlate with Clinical Outcomes in Breast Cancer
    Stephanie Cabarcas‐Petroski, Laura Schramm · 2022 · Cancers
  4. Therapeutic Potential of PLK1, KIF4A, CDCA5, UBE2C, CDT1, SKA3, AURKB, and PTTG1 Genes in Triple-Negative Breast Cancer: Correlating Their Expression with Sensitivity to GSK 461364 and IKK 16 Drugs
    Najmeh Bashari, Mohammadamin Naghizadeh, Mehrnaz Kalhor Chegini, Ensieh Sagheb Sadeghi, Atefeh Zamani, Mohammad Mahdevar · 2024 · Biochemical Genetics
  5. The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation
    Song Hee Kim, Won Hyeok Lee, Daseul Seong, Jae Hee An, Hyoung Uk Je, Hae Yun Nam, Sang Yoon Kim, Seong Who Kim, Myung Woul Han · 2019 · Head & Neck
  6. Cip2A modulates osteogenic differentiation via the ERK‐Runx2 pathway in MG63 cells
    Hyo‐Eun Son, Won‐Gu Jang · 2021 · BioFactors
  7. Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer’s Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy
    Sheng Li, Rajiv Bhalla · 2024 · Neurochemical Research
  8. Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases
    Howard K.Y. Yu, Sahil Zaveri, Zeeshan Sattar, Michael Schaible, Brais Perez Gandara, Anwar Uddin, Lucas R. McGarvey, Michael H. J. Ohlmeyer, Patrick M. Geraghty · 2023 · Medicina
  9. Exploring the composition of protein-ligand binding sites for cancerous inhibitor of PP2A (CIP2A) by inhibitor guided binding analysis: paving a new way for the Discovery of drug candidates against triple negative breast cancer (TNBC)
    Oluwayimika E. Ibitoye, Mahmoud A. A. Ibrahim, Mahmoud E. S. Soliman · 2023 · Journal of Receptors and Signal Transduction
  10. Promising Molecular Targets in Pharmacological Therapy for Neuronal Damage in Brain Injury
    Cristóbal de los Rı́os, Lucía Viejo, Victoria Jiménez, Natalia Hernández Juárez, Natália Alves Martins, Jesús Miguel Hernández-Guijo · 2023 · Antioxidants
  11. AG8 induces apoptosis and ferroptosis through regulating caspase 3 and SLC7A11/GPX4 signaling pathway in triple-negative breast cancer
    Hong Yan, Sishuo Wang, Yuan Hu, Rui Jing, Lijun Liu, Ping Liu, Hong Yan Yin, Li-Hua Mu · 2025 · Clinical Traditional Medicine and Pharmacology
  12. Original Article Knockdown of CIP2A sensitizes ovarian cancer cells to cisplatin: an in vitro study
    Xiaoli Zhang, Bin Xu, Chuanying Sun, Liming Wang, Xia Miao · 2015
  13. Investigating the Role of Protein Arginine Methyltransferases in Breast Cancer Etiology
    Alan Morettin · 2015 · uO Research (University of Ottawa)
  14. Human Oncoprotein and a Potential Cancer Therapy Target Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging
    Anchit Khanna, John E. Pimanda, Jukka K. Westermarck · 2013
  15. Effect of miR-375 on non-small cell lung carcinoma invasion, migration, and proliferation through the CIP2A pathway
    Junyu Wu, Weijun Yuan, Yuhuan Wang, Xiaodong Zhao · 2020 · Oncology and Translational Medicine
  16. Combination of Second-Generation Proteasome Inhibitor Carfilzomib with Bortezomib in Four Different Breast Cancer Cell Lines
    Ergül Mutlu Altundağ, Ayşe Mine Yılmaz, Ali Şahin, Betul Karademir-Yilmaz · 2022 · Anti-Cancer Agents in Medicinal Chemistry
  17. The Emerging Role of the Cancerous Inhibitor of Protein Phosphatase 2A in Pulmonary Diseases
    Hamza Hamza, Dinesh Nirmal, Stephanie Pappas, Ugochukwu Jerome Ebubechukwu, Sunydip Gill, A Al-Ajam, Michael H. J. Ohlmeyer, Patrick M. Geraghty · 2025 · Medicina
  18. Dual Immunological Prognostic Models for Risk Stratification and Treatment Insights in Triple-Negative Breast Cancer
    Shihua Lin, HongJiu Wang, Zhenzhen Wang, Yuxuan Xiao, Menoudji Djetoyom Patrice, L. Wang, Xia Li, Yunpeng Zhang · 2026 · International Journal of Molecular Sciences
  19. Implication du métabolisme de la sérotonine dans les cancers du sein triple négatifs et perspectives cliniques
    Alice Marques Pinheiro · 2019 · theses.fr (ABES)
  20. IGF1 Receptor Inhibition Amplifies the Effects of Cancer Drugs by Autophagy and Immune-Dependent Mechanisms
    Ai-Ling Tian · 2022 · theses.fr (ABES)
  21. Therapeutic Approaches Targeting the Ubiquitin System
    Kezban Uçar Çifci, Büşra Büyük, Şeyma Sağır, Ayşe Büşranur Çelik, Yusuf Tutar · 2026 · IntechOpen eBooks
  22. PP2A targeting: balancing anticancer potential and neurological risk
    Margarita Chigriai, Nina Kraskovskaya, Anastasia Bolshakova, Natalia O. Porozova, Yuri B. Porozov, Milica Pešić · 2026 · Frontiers in Cell and Developmental Biology